NCT06481592 A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. Status RECRUITING Phase PHASE2
NCT06475599 Anlotinib Hydrochloride Capsules Combined With TQB2450 in the Treatment of Endometrial Cancer Status NOT_YET_RECRUITING Phase PHASE3
NCT06463028 Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer Status RECRUITING Phase PHASE2
NCT06409052 Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women Status RECRUITING Phase N/A
NCT06395519 A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies Status RECRUITING Phase PHASE1/PHASE2
NCT06385548 Efficacy and Safety Study of Lurbinectedin and Dostarlimab in Cancer Patients: Protocol VHIO21001 - LiDer Status WITHDRAWN Phase PHASE1/PHASE2
NCT06360653 a SIngle Center Study of Post-operative STEReotactic RAdiotherapY for Endometrial Cancer Status RECRUITING Phase NA
NCT06354738 Improving Endometrial Cancer Assessment by Combining Genomic Profiling and Surgical Assessment Status RECRUITING Phase NA
NCT06341855 Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer Status RECRUITING Phase NA
NCT06340568 A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer Status RECRUITING Phase PHASE3
NCT06321068 BAT1308 in Combination With Platinum-containing Chemotherapy is Used for the First-line Treatment of Advanced or Recurrent dMMR Endometrial Cancer Status TERMINATED Phase PHASE2/PHASE3
NCT06307886 Comparison of Five-year Survival and Disease-free Survival in Patients Diagnosed With Endometrium Cancer Who Underwent Total Laparoscopic Hysterectomy With and Without Uterine Manipulator Status RECRUITING Phase N/A